Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07382349 · ClinicalTrials.gov registry record · NA
A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease
A NA study, sponsored by Vanderbilt University Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 7,200
- Enrollment target
NCT07382349: Clinical Trial NA study, sponsored by Vanderbilt University Medical Center.
NCT07382349 is a NA study that has not yet begun recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 7,200 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (413% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07382349, a NA study, has not yet begun recruiting, sponsored by Vanderbilt University Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 7,200 participants
- Enrollment target
Study Summary
The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decision making for participants with metabolic-dysfunction associated steatotic liver disease (MASLD), and to determine the acceptance and barriers for use of an electronic health record embedded algorithm for MASLD care management within ambulatory primary care, endocrinology, and general gastroenterology settings.
Primary Outcome
Number of participants with new referrals placed to Hepatology for evaluation of high-risk status
Interventions
- OTHER eMPOWER Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,200 participants |
| Start Date | 2026-07 |
| Est. Completion | 2030-02 |
| Phase | NA |
What is known before NCT07382349 opens enrollment
NCT07382349 is an interventional study that assigns participants to a tested intervention. Its 7,200 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (413% higher).
The record links to 0 conditions, and to 1 intervention - of which eMPOWER Decision Aid is the first listed.
NCT07382349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07382349 about?
NCT07382349 is a clinical study titled "A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease". The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decision making for participants with metabolic-dysfunction associated steatotic liver disease (MASLD), and to determine the acceptance and barriers...
What is the current status of trial NCT07382349?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 7,200 participants. The study started on 2026-07. Estimated completion is 2030-02.
What interventions are being tested in trial NCT07382349?
The interventions under investigation include: eMPOWER Decision Aid (OTHER).
Who is sponsoring clinical trial NCT07382349?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07382349's enrollment target sits among peer trials
7,200 20th of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05049837 · 7,200 participants
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
- NCT06714929 · 7,200 participants · NA
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia